Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret Hofstedt

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Pediatrics|March 12, 2025
Erythematous Neck Folds in InfantMargaret Hofstedt, Yucong Zhang, Meg G Keeley, et al.
The Journal of Climate Change and Health|February 6, 2026
Serving Up Climate Education: An innovative resident curriculum addressing climate change through plant-based solutionsElizabeth Cerceo, Karen Cohen, Krystal Hunter, et al.
Annals of Surgical Oncology|December 25, 2019
The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database AnalysisEliahu Bekhor, Jacquelyn Carr, Margaret Hofstedt, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|January 11, 2021
The role of molecular biomarkers in outcomes and patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal originDaniel Solomon, Natasha Leigh, Eliahu Bekhor, et al.
Annals of Surgical Oncology|August 7, 2019
Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite ExperienceDaniel Solomon, Eliahu Bekhor, Natasha Leigh, et al.
Annals of Surgical Oncology|August 21, 2019
Correction to: Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite ExperienceDaniel Solomon, Eliahu Bekhor, Natasha Leigh, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Pediatrics|March 12, 2025
Erythematous Neck Folds in InfantMargaret Hofstedt, Yucong Zhang, Meg G Keeley, et al.
The Journal of Climate Change and Health|February 6, 2026
Serving Up Climate Education: An innovative resident curriculum addressing climate change through plant-based solutionsElizabeth Cerceo, Karen Cohen, Krystal Hunter, et al.
Annals of Surgical Oncology|December 25, 2019
The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database AnalysisEliahu Bekhor, Jacquelyn Carr, Margaret Hofstedt, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|January 11, 2021
The role of molecular biomarkers in outcomes and patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal originDaniel Solomon, Natasha Leigh, Eliahu Bekhor, et al.
Annals of Surgical Oncology|August 7, 2019
Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite ExperienceDaniel Solomon, Eliahu Bekhor, Natasha Leigh, et al.
Annals of Surgical Oncology|August 21, 2019
Correction to: Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite ExperienceDaniel Solomon, Eliahu Bekhor, Natasha Leigh, et al.
Pageof 1